Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Technology Trust Regulatory News (PCT)

Share Price Information for Polar Capital Technology Trust (PCT)

Share Price is delayed by 15 minutes
Get Live Data
684.00    -26.00 (-3.66%)
Bid:
680.00
Ask:
681.00
Spread: 1.00 (0.147%)
Market Cap: £7.61b
PCT Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Technology Trust Share Chart

Annual Overview from QuotedData

16 Jan 2025 13:24

RNS Number : 6437T
Polar Capital Technology Trust PLC
16 January 2025
 

Polar Capital Technology - Annual Overview from QuotedData

16th January 2025

AI captain

Polar Capital Technology's (PCT's) manager contends that it has never been a better time to be an active manager in the artificial intelligence (AI) driven technology sector, with potential winners diversifying from the magnificent seven (Mag7) technology stocks (a group of seven major technology companies that have demonstrated significant influence and performance in financial markets, particularly in recent years - Apple, Microsoft, Aplhabet, Amazon, NVIDIA, Tesla and Meta Platforms) to a range of sectors and companies. Reflecting this, the fund's active share is as large at 50% as it has ever been, on the expectation that the spread in performance between large-cap and small- and mid-cap technology stocks will narrow considerably.

AI innovation, capex and adoption rates have all continued their rapid growth since our last note six months ago, which should act to quell fears of an AI-induced technology valuation bubble. The pace of corporate adoption has been particularly impressive, with several use-cases pointing to vast efficiency and productivity gains, suggesting a snowball in adoption. The skills of an active manager such as PCT's in picking AI winners (and identifying incumbent casualties) makes its 12.3% discount to net asset value (NAV) look good value.

Full Research:

https://quoteddata.com/research/polar-capital-technology-ai-captain-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Polar Capital Technology Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADFKFFLSEFA
Date   Source Headline
1st Aug 20245:09 pmRNSTransaction in Own Shares
1st Aug 20245:04 pmRNSHolding(s) in Company
1st Aug 20244:25 pmRNSTotal Voting Rights
1st Aug 202411:54 amRNSNet Asset Value(s)
31st Jul 202411:39 amRNSNet Asset Value(s)
30th Jul 202412:22 pmRNSNet Asset Value(s)
29th Jul 202412:32 pmRNSNet Asset Value(s)
26th Jul 202412:08 pmRNSNet Asset Value(s)
25th Jul 20245:10 pmRNSTransaction in Own Shares
25th Jul 202412:55 pmRNSNet Asset Value(s)
24th Jul 202412:38 pmRNSNet Asset Value(s)
23rd Jul 202412:05 pmRNSNet Asset Value(s)
22nd Jul 20245:13 pmRNSTransaction in Own Shares
22nd Jul 202412:41 pmRNSNet Asset Value(s)
19th Jul 202412:43 pmRNSNet Asset Value(s)
18th Jul 202412:54 pmRNSNet Asset Value(s)
17th Jul 20245:12 pmRNSTransaction in Own Shares
17th Jul 202412:07 pmRNSNet Asset Value(s)
17th Jul 20247:05 amRNSProposed Share Split
17th Jul 20247:00 amRNSFinal Results
16th Jul 20245:12 pmRNSTransaction in Own Shares
16th Jul 202412:43 pmRNSNet Asset Value(s)
16th Jul 20249:12 amRNSFactsheet
15th Jul 202411:56 amRNSNet Asset Value(s)
12th Jul 202411:26 amRNSNet Asset Value(s)
11th Jul 202411:48 amRNSNet Asset Value(s)
10th Jul 202411:59 amRNSNet Asset Value(s)
9th Jul 20245:22 pmRNSTransaction in Own Shares
9th Jul 202411:54 amRNSNet Asset Value(s)
8th Jul 20245:15 pmRNSTransaction in Own Shares
8th Jul 202412:24 pmRNSNet Asset Value(s)
5th Jul 20245:28 pmRNSTransaction in Own Shares
5th Jul 202412:15 pmRNSNet Asset Value(s)
4th Jul 202411:30 amRNSNet Asset Value(s)
3rd Jul 20245:16 pmRNSTransaction in Own Shares
3rd Jul 20244:54 pmRNSTop Fifteen Equity Holdings and Exposures
3rd Jul 202411:47 amRNSNet Asset Value(s)
2nd Jul 20245:12 pmRNSTransaction in Own Shares
2nd Jul 202412:28 pmRNSBlock listing Interim Review
2nd Jul 202412:09 pmRNSNet Asset Value(s)
1st Jul 20245:09 pmRNSTransaction in Own Shares
1st Jul 20243:31 pmRNSTotal Voting Rights
1st Jul 202411:42 amRNSNet Asset Value(s)
28th Jun 20245:15 pmRNSTransaction in Own Shares
28th Jun 202412:12 pmRNSNet Asset Value(s)
27th Jun 20245:26 pmRNSTransaction in Own Shares
27th Jun 202411:34 amRNSNet Asset Value(s)
26th Jun 20245:11 pmRNSTransaction in Own Shares
26th Jun 202412:12 pmRNSNet Asset Value(s)
25th Jun 20245:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.